Physician profile
Ashley Alexandra Wright
NPI 1164082004
$1,349.08
in general payments reported to CMS, 2019-2025
17 companies · $272 in 2025
The $272 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $267 · 2023: $507 · 2024: $303 · 2025: $272.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $966 · Education: $116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $966.38 |
| Education | $116.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $277.68 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $255.95 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Innovation Technologies INC | $155.81 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $125.42 | 2022-2025 | Farxiga, Breztri, Airsupra |
| Abbvie INC. | $106.75 | 2022-2024 | Ubrelvy, Qulipta |
| Pfizer INC. | $87.63 | 2023-2024 | |
| Exact Sciences Corporation | $67.05 | 2023-2025 | Cologuard Collection Kit |
| Inspire Medical Systems, INC. | $47.38 | 2025 | Inspire |
| Amgen INC. | $46.71 | 2024 | Otezla, Repatha |
| Boston Scientific Corporation | $34.02 | 2025 | Wavewriter Alpha Prime 16 |
| Travere Therapeutics, INC. | $30.95 | 2023 | |
| Sanofi-Aventis U.S. LLC | $28.73 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.32 | 2023 | |
| Glaxosmithkline, LLC. | $18.71 | 2024 | Trelegy Ellipta |
| Amneal Pharmaceuticals LLC | $17.45 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $14.43 | 2023 | Gardasil 9 |
| Esperion Therapeutics, INC. | $14.09 | 2025 | Nexletol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.